WASHINGTON, D.C. / RankWire.AI / – Colorectal cancer remains a major health concern worldwide, prompting ongoing research into factors that may influence its development. Recent findings suggest that the removal of the appendix during treatment for acute appendicitis could be associated with a significantly lower incidence of colorectal cancer later in life. A new retrospective investigation compared patient groups from an extensive international health database to explore this potential connection. Researchers observed colorectal cancer in 0.7% of individuals who underwent an appendectomy, compared to 1.7% among those treated solely with antibiotics. This difference indicates a 58% lower relative risk among the surgical group.
Utilizing the TriNetX Global Collaborative Network, which aggregates data from 168 healthcare organizations, the study identified patients diagnosed with acute appendicitis who either received surgical removal or antibiotic therapy. After matching patients based on relevant characteristics, each group initially comprised 15,774 individuals. Following exclusion of those with prior colorectal cancer diagnoses, the final analysis included 15,616 patients who had an appendectomy and 15,295 who received only antibiotics. Researchers documented 110 cases of colorectal cancer following appendectomy and 254 cases after antibiotic treatment.
The findings were presented at the American College of Surgeons Clinical Congress 2026, held in Washington from September 26 to September 29. The research abstract was reviewed and selected by the Scientific Forum program committee. However, no peer review by a medical journal has yet occurred, which limits the strength of the conclusions that can be drawn. While the study demonstrates an association between treatment method and subsequent colorectal cancer diagnosis, it does not establish that appendix removal actively prevents the disease.
Comparison of Surgical and Antibiotic Approaches
Acute appendicitis involves inflammation of the appendix, a small organ located near the junction of the small and large intestines. Traditionally, the standard treatment has been surgical removal, known as an appendectomy. In recent years, antibiotics have gained acceptance as an alternative approach for selected cases. Valentine Nfonsam, a senior author and professor as well as executive vice chair of surgery at Morehouse School of Medicine, emphasized that despite the findings, antibiotic therapy remains a vital treatment option.
The study also examined variables that could influence the development of colorectal cancer following appendicitis treatment. It is possible for a patient to have an undiagnosed colorectal tumor that causes appendicitis, especially if a tumor on the right side of the colon obstructs the appendix and triggers inflammation. Additionally, surgery allows for tissue examination, which can uncover abnormalities and prompt further diagnostic tests that are not typically performed immediately with antibiotic-only treatment.
The Study Does Not Confirm Cancer Prevention
The appendix plays a role in immune function, containing lymphoid tissue and contributing to the gut microbiome, which involves bacteria and other microorganisms within the digestive system. The recent research did not clarify whether these biological roles account for the observed differences in colorectal cancer diagnoses, nor did it determine if inflammation or microbial changes are causative factors. Consequently, researchers refrain from suggesting that appendectomy can serve as a preventive measure against colorectal cancer.
Previous studies have yielded varying results regarding the link between appendectomy and colorectal cancer. For instance, a 2024 prospective analysis tracked over 224,000 participants across three large cohorts for up to 32 years, finding no evidence that appendectomy raises long-term risks of colorectal cancer or precursors. This new study, however, focuses on comparing patients with appendicitis treated surgically against those receiving antibiotics alone. The researchers also noted that factors such as age, family history, and genetic predisposition are well-established in assessing colorectal cancer risk.